01
Biography
With over two decades of experience at the intersection of biotechnology and venture capital, Ruvin Orbach has dedicated his career to advancing cellular immunotherapy. As a co-founder and executive, he has led the development of innovative cancer treatment technologies, bridging the gap between laboratory breakthroughs and clinical reality. His mission is to connect visionary science with the resources needed to transform global health through precision medicine and cutting-edge innovation.
Career Highlights
Co-Founder & CEO
Orbach founded a leading biotechnology firm focused on cellular immunotherapy, bridging the gap between laboratory research and clinical application.
Investor & Advisor
He has served as a strategic advisor to multiple biotech startups, providing critical capital and operational guidance to accelerate innovation in oncology.
Entrepreneurial Leader
Orbach has successfully navigated the complexities of venture capital, identifying and scaling high-impact cellular immunotherapy technologies for global markets.